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Recent advances in the isolation of tissue-resident adult stem cells and the identification 
of inductive factors that efficiently direct differentiation of human pluripotent stem cells 
(hPSCs) along specific lineages have facilitated the development of high-fidelity 
modelling of several tissues in vitro. Many of the novel approaches used have employed 
self-organising three-dimensional (3D) culturing of organoids, which offer several 
advantages over conventional two-dimentional platforms. Organoid technologies hold 
great promises for modelling diseases and predicting the outcome of drug responses in 
vitro. Here, we outline the historical background and some of the recent advances in the 
field of 3D organoids. We also highlight some of the current limitations of these systems 
and discuss potential avenues to further benefit biological research using 3D modelling 
technologies.     
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The isolation and maintenance of mammalian cells have significantly advanced scientific 
research into cellular processes and mechanisms of disease that include stem cell 
development and differentiation, the production of monoclonal antibodies, and 
therapeutic proteins and for modelling cancer in vitro (1). Although culturing tissues 
dates back to the late nineteenth century, present cell culture systems draw from 
studies on the action of serum on fibroblast cells (2) and the development of novel 
synthetic cell culture media (3, 4). A classic example of this was the isolation and 
expansion of HeLa cells from a cervical tumour on a two-dimensional (2D) monolayer 
culture (5).  
Since then, culturing cells in 2D has remained the predominant methodology of in vitro 
cell growth and expansion. However, the 2D platforms do not effectively recapitulate 
the spatial requirements that are essential for the organisation and cellular interactions, 
which occur in vivo. In addition, it is suspected that limited cell-cell contact and altered 
in vitro cell signalling networks can result in major discrepancies between the data 
acquired from 2D in vitro versus in vivo research.  
Historical background 
To overcome 2D platform limitations, efforts have led to development of novel 
approaches to recreate a more physiologically relevant environment in the form of 3D 
cell culture (1). To successfully construct and maintain a 3D structure, much research 
has been devoted to the development of synthetic or natural polymeric 3D scaffolds to 
facilitate cell growth. These efforts have resulted in the fabrication and characterisation 
of several non-degradable or biodegradable synthetic polymers such as poly-lactic acid, 
poly-glycolic acid, poly-lactic-co-glycolic acid and poly caprolactone (6). Initially, a “top-
down” approach was adopted where cells were seeded on a prefabricated scaffold, 
however, difficulties in recreating the intricate microstructural characteristics of tissues 
have remained the major limitation of this approach (7). Later, “bottom-up” assembly of 
small cellularised blocks and layer-by-layer assembly (also known as 3D printing) have 
been developed (8). In this review, we focus on scaffold-free methods to culture cells in 
3D and the generation of organoids by embedding cells in semi-solidified extracellular 
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matrices (ECM) in contrast to the use of polymeric scaffolds and 3D printing, which have 
been reviewed extensively elsewhere (6, 9, 10). 
Techniques to generate scaffold-free 3D cellular aggregates  
In general, scaffold-free approaches rely on cell-cell interaction and can be categorised 
into passive or active methodologies. The passive methodologies solely rely on cell 
adhesion properties, in which cells require time to form solid aggregates (11). Various 
passive methods have been developed to generate scaffold-free 3D aggregates robustly 
and consistently (Fig. 1).  
Hanging-drop is the first technique to generate 3D structures by culturing suspended 
droplets of desired cell line(s) to force aggregation (Fig. 1a). In fact, Robert Koch et al. 
invented the hanging-drop methodology in the 1880s to grow anthrax bacilli in a 
suspended drop of fluid taken from oxen eyes in a special concave microscope slide 
(12). Later, this method was adopted by Harrison and co-workers to monitor nerve 
outgrowth (13). Harrison’s pioneering work led to the development of various 
techniques for short-term culture of dissected tissues during the early 20th century. 
Although 3D spheroids can be generated efficiently using this technique, the lack of 
scalability promoted the development of high-throughput culture methods that use 
384-hanging drop arrays, which are amenable to automation (14, 15).  
Later, the liquid overlay method was developed to generate 3D microtissues on non-
adherent surfaces. Using this method, random interactions of cells resulted in the 
formation of large numbers of spheroids, which were usually heterogeneous in size (16, 
17). As the nutrients and oxygen exchange is based on passive diffusion in static culture, 
formation of necrotic centres in large spheroids is a major drawback of this 
methodology (18). To improve consistency and control, the size of formed microtissues, 
micromoulds (Fig. 1b) and patterned microplates have more recently been used (19). 
More advanced methodologies have also been developed for large scale production of 
3D microtissues, which include, spinner flasks, rotating wall vessel bioreactors, and 
microfluidic systems (Fig. 1c).  
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b. Microplate mould 
 
 
c. Stirred flask culture 
 
 
Figure 1: Methods for generation of 3D microtissues. (a) Hanging drop is the first method of 
generating and maintaining 3D structures in culture. (b) 3D micromoulds have been 
introduced to the field to overcome both culture media restriction of the hanging drop 
method and size heterogeneity of spheroids formed in liquid overlay methodology. (c) The use 
of spinner flask is one of the more advanced methodologies, which is developed for large-
scale production and maintenance of 3D microtissues.      
As it is difficult to robustly generate 3D microtissues from more than one cell type, 
several active techniques have been developed to overcome this problem. Active 
methodologies use additional physical stimuli such as ultrasound traps, electric fields, 
magnetic forces, or the strong affinity between avidin and biotin to generate 
multicellular heterospheroids (20-23). 
3D organoid formation 
Derivation of reconstituted collagen from rat tail (24), discovery of fibronectin (25, 26), 
isolation of a matrix from chondrosarcoma murine cells (27) and characterisation of 
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laminin (28) have set the building blocks for subsequent progress in the field of 3D cell 
culture. In 1989, Barcellos-Hoff and colleagues reported the functional differentiation 
and alveolar morphogenesis of primary mammary cultures on a reconstituted basement 
membrane matrix derived from Engelbreth-Holm-Swarm murine tumour, today known 
as MatrigelTM (29). However, it took nearly two decades to widely utilise the self-
organising capacity of cells cultured in this laminin-rich ECM to form 3D organ-like 
structures known as organoids (30). The generation of organoids has made significant 
impact and led to the establishment of organoid culture from various tissues (Fig. 2), 
which will be discussed in more details here. 
 
Figure 2: Schematic representation of some of the organoids generated from PSCs. Embryonic 
stem cells (ESCs) are generated following expansion of cells isolated from the inner cell mass 
of an embryo at the blastocyst stage while iPSCs can be generated from somatic cells 
following reprogramming by key master regulators known as Yamanaka factors. Organoids of 
various tissues have been generated following treatment of MatrigelTM-embedded PSCs by 
cocktails of various growth factors. They can also be generated following isolation and culture 
of specific populations of progenitor cells, which maintain homeostasis of tissues during 
adulthood such as cells expressing Leucine-rich repeat-containing G-protein coupled receprot 
5 (LGR5). 
An insight into 3D organoid cultures 
The production of 3D organoid-based culture systems from multiple organs has received 
considerable attention over the last ten years (31). The term ‘’organoid’’ is defined as 
Page 6 of 25
http://mc.manuscriptcentral.com/issue-ptrsb
































































self-organising 3D structures that are cultured in vitro while embedded in an ECM. 
These 3D structures closely resemble their organ of origin (32). Organoids can be 
derived from various cell sources such as primary tissue, cell lines, adult stem cells 
(ACS), and pluripotent stem cells (PSCs) (33). Organoids from human PSCs (hPSCs) are 
great tools to enhance our knowledge of human embryonic development while ASC-
derived organoids can closely mimic the in vivo stem cell niche and can be considered as 
useful tools to enhance our understanding of the underlying mechanisms involved in 
tissue regeneration following injury. 
Organoids derived from the intestine and colon  
The epithelium of intestine is derived from the definitive endoderm (DE) during 
embryonic development (34). In a pioneering work, Ootani et al. developed an air-liquid 
interface model by culturing f agments of intestine, which contained mesenchymal and 
epithelial cells from neonatal mice. In this model, cyst-like structures were formed in a 
medium supplemented with foetal bovine serum (FBS). Interestingly, these cyst-like 
structures were composed of all major cell types of the adult mouse intestine and could 
be maintained for over one year in culture (35).  
Later on, Hans Clevers’ research group proposed an alternative technique that aided the 
formation of epithelial organoids (mini-guts) from single Lgr5+ stem cells. The LGR5 
protein is produced by small population of stem cells residing in a variety of adult 
organs including intestine, stomach, kidney, and skin (36). By using a specialised cell 
culture medium and the support of MatrigelTM as an ECM, the stem cell niche of the 
crypt was mimicked and enabled long-term survival of LGR5+ cells (37). These 
“organoids” were composed of a central lumen surrounded by outgrowths or “buds”, 
which resemble the intestinal crypts and make them distinctive from the cystic 
structures previously described by Ootani and co-workers (37). In this model, self-
renewal of the stem cell population relied on LGR5+ stem cells, which terminally 
differentiated into enterocytes, and enteroendocrine or goblet cells. This 
methodological advancement played a key role in mimicking near-physiological 
conditions of in vivo mouse models whilst having an easy-to-maintain in vitro culture 
system (37). Due to the low level of Lgr5 expression, other research groups have 
investigated other stem cells markers such as CD24 (38), EphB2 (39) and CD166+/GRP78 
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(40) to generate intestinal organoids. In addition, a step-wise protocol was developed to 
generate intestinal organoids from hPSCs using Activin A to induce initial transition into 
DE. Then WNT3A and BMP4 were used to promote hindgut and intestinal specification 
(41). 
Liver organoids  
During embryonic development and early hepatogenesis, progenitor cells migrate from 
the foregut endoderm to form a very dense and vascularised ‘liver buds’. The key cross-
signalling pathways between mesenchymal, endodermal epithelial and endothelial 
progenitors have been studied extensively using these to better understand human liver 
development. In an attempt to recapitulate liver development, 3D aggregates were 
formed by culturing human PSC-derived hepatocytes with mesenchymal stem cells and 
endothelial cells on a MatrigelTM-coated plate.  It was reported that these liver 
aggregates contained blood vessels and following transplantation into mice become 
connected to the host vessels within 48 hours. The functional activity of the liver as 
determined by protein production and drug metabolism activity was significantly 
increased over time. Further, the recipient mice were recovered from drug-induced liver 
failure following liver bud transplantation (42). 
Hepatocytes and bile duct cells are the two major cell types of the liver, which have 
extremely slow turn-over in comparison with the small intestine and colon. In the 
healthy adult mouse liver, Lgr5 is not expressed at high levels. However, upon tissue 
damage or injury, small Lgr5+ cells located near bile ducts with high level Wnt signalling. 
It has been reported that following tissue injury, hepatocytes and bile duct cells are 
generated in vivo. With slight alteration, the single Lgr5+ cells could be clonally 
expanded as organoids by inhibiting notch signalling pathway and differentiation into 
functional hepatocytes (43). In a similar study, culture conditions were optimised for the 
long-term expansion of human liver progenitor cells. Similarly, long-term expanded liver 
organoids remained genetically stable and were transplanted into recipient mice to 
provide liver support (44).  
Pancreatic organoids 
The adult pancreas is composed of several different cell types such as exocrine/acinar 
and endocrine cells with a very slow turn-over. Similar to the liver, under normal 
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physiological conditions, WNT signalling pathway is not active and the Lgr5 gene is not 
highly expressed in the pancreas. Upon tissue injury, the WNT signalling is activated 
while pancreatic ducts regenerate through proliferation of Lgr5+ cells. In a similar setting 
to the mini-gut culture condition, clonal pancreas organoids were differentiated and 
successfully transplanted in vivo (45). In an elegant study, Boj and colleagues 
established organoid models from both normal and neoplastic murine and human 
pancreatic tissues. Interestingly, these organoids exhibited ductal- and disease stage-
specific characteristics and recapitulated tumour progression following in vivo 
transplantation (46).  
Lung organoids   
The lung is derived from Nkx2-1+ progenitor cells, which are generated in the ventral 
foregut endoderm region during embryonic development. In a pioneering work, a 
cytokeratins 5 (Krt5)-CreERT2 transgenic mouse model was used to trace and 
characterise basal cells which act as progenitors to generate differentiated cells during 
postnatal growth and repair. Following identification of ITGA6 and NGFR as two specific 
cell surface markers, an organoid culture was established to generate both mouse and 
human luminal cells including differentiated ciliated cells (47). The generation of lung 
organoids from PSCs have also been investigated. In an early attempt, induction of PSCs 
toward the endodermal fate was achieved following Activin A induction and TFG-/BMP 
inhibition and subsequent combinatorial induction of BMP and FGF signalling to 
generate lung progenitors, which can recapitulate the early embryonic development of 
the lung (48). More recently, an efficient protocol was developed to generate most cell 
types of the respiratory system including basal, goblet, Clara, ciliated, type I and type II 
alveolar epithelial cells capable of performing specific functions such as surfactant 
protein-B uptake and stimulated surfactant release (49).  
Stomach Organoids 
During embryogenesis, the stomach derives from the posterior foregut. Stomach 
organoids have been generated from both ASCs and PSCs. D’amour and colleagues 
proposed a method for the efficient derivation of DE from hESCs. It was reported that in 
the presence of Activin A and low serum, up to 80% of the cells were differentiated into 
DE cells. It was also suggested that the process of differentiation into DE requires 
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epithelial-to-mesenchymal transition (EMT) (50). Later, it was shown that DE can be 
derived from PSCs with only Activin A following temporal manipulation of retinoic acid, 
FGF, WNT, BMP, and EGF signalling pathways to generate 3D human gastric organoids 
(51). In addition, gastric organoids can be generated from single Lgr5+ cells that reside at 
the base of pyloric glands of the adult mouse stomach. Importantly, generated 
organoids closely recapitulate mature pyloric epithelium and can be expanded and 
maintained for an extended period in culture (52). Moreover, at the base of the gastric 
corpus there are specialised chief cells called Troy cells. Upon exposure to damage, 
these cells undergo dedifferentiation to become multipotent epithelial stem cells in 
vivo. Using this knowledge, gastric organoids were generated by culturing Troy+ chief 
cells, which contains various cell types of corpus glands (53).  
Brain organoids 
During embryonic development, neural ectoderm forms the central nervous system 
(CNS), initially through formation of the neural plate, which subsequently forms the 
neural tube via folding and fusion. Similar to other organs, morphogenic gradients in the 
tube establish a dorsal-ventral and a rostral-caudal axis. Neurons are the major cell 
types of the CNS and they are generated from neural stem cells (NSC), which located 
near the ventricles (54, 55).  
In ESC culture, spontaneous neural differentiation can be achieved following inhibition 
of signalling pathways such as BMP, Nodal, and WNTs. This process is very similar to the 
neural-default mechanism of ESCs. Based on this knowledge, Sasai and colleagues 
developed SFEBq: serum-free floating culture of embryoid body (EB)-like aggregates 
with quick re-aggregation (56). In this culture setting, ESCs were isolated from the 
growth-factor free 2D cultures. The cells were then re-aggregated in 96-well non-
adhesive culture plates. The cells were maintained in serum-free medium containing no 
or a very low levels of growth factors for 7 days, after which they were transferred into 
adhesion plates. Following formation of the lumen, ESCs polarise and differentiate to 
generate polarised a neuroectoderm-like epithelium. It was further concluded that 
under certain conditions, the embryonic spatial and temporal events can be 
recapitulated in vitro, which can in turn lead to the generation of neural structures in 
the brain (56).  
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In another study, cerebral organoids were generated and called “mini-brains” as several 
regions of the brain were represented in each organoid. Very similar to the previous 
study, the floating EBs were cultured in absence of growth factors to derive specific 
brain region identity. Further, aggregates were embedded in a laminin-rich ECM. With 
this technique, large neuroepithelial buds were formed representing different brain 
regions. Interestingly, it was reported that brain regions such as retina, ventral 
forebrain, midbrain-hind-brain boundary, and dorsal cortex were observed in these 
cultures (55).  
Retinal organoids 
Embryonic development of the retina occurs through lateral evagination of the 
diencephalon, which in turn forms pseudostratified neuro-epithelial known as optic 
vesicles (OVs). Later, sensory neural retina (NR) is derived from the distal portion of the 
OVs, while the proximal portion gives rise to retinal pigment epithelium (RPE). Following 
invagination of OVs at their distal portion, a bi-layered optic cup (OC) is formed with the 
RPE and NR as its outer and inner walls, respectively. The NR progenitor cells give rise to 
photoreceptors (rods and cones), ganglion cells, and all supportive cell types (57). 
Pioneering work in chick embryos that demonstrated the retinal capacity to form 
different cell types in the distinct laminated structure of retina paved the way for 
development of PSC-derived retinal organoids (58). 
Following an initial studies that demonstrated the successful formation of retinal 
epithelium from 3D floating mESC-derived EB-like aggregates in a low-serum medium 
(59), retinal organoids were generated from self-organising hESCs forming a multi-
layered tissue containing both rod and cone photoreceptors. Remarkably, retinal 
organoids formed from hESCs were much larger in size than organoids derived from 
mESCs, potentially reflecting the species-specific differences (60).  
Other organs 
More recently, organoids from other organs such as the prostate (61), fallopian tube 
(62), mammary gland (63, 64), taste buds (65), salivary glands (66, 67), and oesophagus 
(68) have all been developed. 
Page 11 of 25
http://mc.manuscriptcentral.com/issue-ptrsb
































































The basal and luminal cells are two major cell types that form the pseudostratified 
epithelium of the prostate. In 2014, a mini-gut-based culture method was developed to 
support the long-term expansion of primary mouse and human prostate organoids. The 
structure of these 3D organoids consisted of mature and differentiated basal and 
luminal cells. It was also reported that luminal cell-derived organoids closely resembled 
prostate glands. Luminal cell induction depends on WNT or R-spondin activation to 
some extent and subsequently this will form prostate-like pseudostratified organoid 
structures (61). Furthermore, an alternative culture system was established to derive 
prostate organoids using MatrigelTM, EGF, and androgen supplementation 
independently (69).  
The fallopian tube is an anatomically simple organ, which is composed of columnar 
epithelium. Secretory cells produce tubular fluid and ciliated cells support the transfer 
of gametes within the tube. Self-renewal capacity of the epithelium is of utmost 
importance due to the monthly cyclical hormonal fluctuations. In 2015, long-term 3D 
organoid culture of the human fallopian tube was established following adaptation of 
mini-gut culture protocols. The resulting clonal organoids were composed of ciliated 
and secretory cells, which provide the opportunity to study human fallopian tube 
epithelium in more details (62).  
Applications of 3D Organoids  
Organoids can be exploited for various applications such as disease modelling, drug 
toxicity testing, organoid biobanking, personalised therapy, and host-pathogen 
interaction studies. In addition, organoids are a useful tool to perform omics analysis 
(transcriptomics, proteomics, epigenomics and metabolomics) of healthy and diseased 
tissues to gain a better understanding of mechanisms underlying pathological 
conditions (70). Some of these applications are discusses below in further detail. 
Disease modelling  
Although several animal models have been generated to recapitulate clinical 
characteristics of human monogenic disorders following introduction of single-gene 
mutations, introduction of such a mutation does not guarantee the recapitulation of the 
clinical features of these disorders in recipient animals. However, organoids generated 
from patient-specific iPSC lines can recapitulate the clinical features of various 
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monogenic disorders and can be used as in vitro models to further study these 
disorders. 
A clear example is an early attempt to generate an in vitro model of cystic fibrosis (CF) 
using patient-derived tissue fragments (71). CF is an autosomal recessive genetic 
disorder caused by a mutation in the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene affecting multiple organs including the lung, intestine, liver, 
pancreas, and reproductive tract (72). Dekkers et al. initially developed an organoid-
based assay, whereby forskolin promoted a rapid swelling of wild type-derived 
organoids from mouse and human intestinal samples through activation of c-AMP. They 
further concluded that the drug-induced swelling was significantly reduced in mice 
carrying the F508del mutation in the CFTR disease model. With the development of this 
advanced methodology, it was suggested that this is a promising tool to study gene 
therapy models to correct CFTR mutations (71). In a follow up study, the same assay 
was used to assess the potential of CRISPR/CAS9 technology to correct the CFTR 
F508del allele. Interestingly, organoids with the correct set of alleles regained the ability 
to swell upon exposure to forskolin. These studies concurrently demonstrated a proof-
of-concept for gene replacement therapy for future clinical translation (73). More 
recently, in vitro organoid models of other monogenic disorders such as Alagille 
syndrome (74), and Retinitis Pigmentosa (75) have been generated, which is reviewed 
more extensively elsewhere (76). 
Cell-based therapies 
Despite advanced in therapeutic regimens, there are various inherited, degenerative 
and, chronic disorders that have remained incurable through conventional approaches. 
Stem cell-based therapies have the potential to alleviate symptoms or possibly cure 
these conditions by replacing damaged or lost cells. The ability to generate organ-like 
structures, which contain representative cell populations of the desired organs has 
made organoid culture a powerful tool to obtain various progenitor cells for cell-based 
therapies.    
In an early attempt, Yui and co-workers prepared a large batch of organoids, which 
originally derived from single Lgr5+ colon stem cells to study long-term genetic stability 
of the organoids. These organoids were transplanted per annum into multiple mice 
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suffering from experimental colitis. They further confirmed that organoids were readily 
integrated and acted as functional epithelial patches, which could not be easily 
distinguished from the host epithelium (77). In another elegant study, improvement of 
vision impairment was successfully demonstrated following transplantation of 
functional rod photoreceptors in adult Gnat1-/- mice, which lack rod function as a model 
of congenital stationary night blindness (78). Therefore, generation of transplantation-
competent photoreceptor precursors from hPSCs have been investigated to treat 
blindness (79-82).  
In addition, multi-lineage approaches have been developed to generate composite 
organoids for the liver, lung, intestine, heart, kidney, and brain (42, 83). Despite 
promising outcomes in the preliminary studies, clinical translation of hPSC-derived 
organoids faces several major challenges including reliance of current protocols on 
undefined and animal-derived ingredients that need to be resolved to facilitate their 
clinical applications.  
Drug screening, organ-on-chips, and personalised medicine
High attrition rate is the biggest challenge facing the pharmaceutical industry. Lack of 
suitable preclinical models to accurately predict efficacy and toxicity of novel lead 
compounds has been considered as one of the major contributors. To improve 
productivity and predictability, 2D cell-based screenings have been used as a convenient 
means to evaluate novel therapeutic candidates. However, the emerging evidences has 
revealed poor predictability of 2D screening platforms for certain diseases such as 
cancers (84). In addition, predictability of preclinical animal models has been a matter of 
debate due to considerable interspecies differences in disease phenotypes and 
reactions to drugs (85-87). Lack of predictability and growing ethical concerns regarding 
the use of laboratory animals have encouraged exploration of new avenues to develop 
novel screening platforms to mitigate the high attrition rate. 
To overcome these issues, various mono- and co-culture 3D systems have been 
developed for oncology research and drug screening. Nutrients, oxygen, metabolites, 
and soluble factors induce the formation of a heterogeneous population of cells within 
3D microtissues to mimic tumour microenvironments more closely than monolayer 
cultures (88).  
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Despite various practical challenges, 3D drug screening platforms have grown in 
popularity and both tumour and healthy organoids of various tissues have been 
generated from patients’ biopsies and ASCs or PSCs. In a pioneering work, Wong et al. 
demonstrated the usefulness of in vitro organoid models for the screening of lead 
compounds following treatment of patient-derived organoids with a novel small 
molecule to correct for a common CF-processing mutation that resulted in enhanced 
membrane localisation of mature CFTR protein (89).  
Considering heterogeneity of tumour pathophysiology, patient-derived organoids have 
proven to be a useful tool for cancer drug discovery. The heterogeneous response of 
neoplastic tumours to anti-cancer treatment was demonstrated following screening of 
83 authorised and experimental anti-cancer agents on tumour organoids derived from 
resected colorectal tissues obtained from 20 patients (90). Similarly, organoids from 
three major subtypes of liver cancers were propagated and used for drug screening. 
Interestingly, liver cancer-derived organoids preserved gene expression, genomic 
landscape, and metastatic properties of the original tumours even after long-term in 
vitro expansion. In addition, SCH772984 (an extracellular signal-regulated kinase (ERK) 
inhibitor) was identified as a potential therapeutic compound for primary liver cancer 
(91).  
Above mentioned studies reiterate the importance of patient-specific organoids to 
identify an appropriate anti-tumour regimen for the efficient treatment of neoplastic 
disorders. To this end, organoid biobanks have been established from patient tumours 
as a valuable tool for drug screening and personalised medicine (90, 92, 93).  
3D organoids have also been used in conjunction with microfluidic devices, known as 
organ-on-chips, as a powerful tool for drug screening. Although organ-on-chips are 
designed to represent functional complexity of a particular organ such as the intestine 
(94) and liver (95), recent efforts have been focused on the development of more 
sophisticated platforms by interconnecting  several organ-on-chips (96). Development 
of such platforms can substitute mandatory preclinical studies in animal models to 
increase the success rate and improve productivity of drug screening while addressing 
growing ethical concerns regarding the use of animal models for drug screening.      
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Modelling infectious diseases to mimic complex interaction between the host and 
pathogens  
The Zika Virus (ZIKV) is a flavivirus, which was isolated from a rhesus monkey in the Zika 
region of Uganda in 1947 and can be transmitted by Aedes species mosquitoes (97). 
Following entry to the human body, ZIKV binds to innate immune Toll-like receptor 3 
(TRL3), which leads to the activation of genes causing disregulation of neurogenesis, 
which is a common side effect seen following ZIKV infection. Using hESC-derived 
cerebral organoids, it was demonstrated that TLR3 inhibition reduced the phenotypic 
effects of ZIKV infection (97).  Other studies also suggested that the mechanism of 
action of this lethal virus is concerned with TRL3-mediated apoptosis, hence cell death 
of neural stem cells (NSC) and impaired development in humans (98, 99). These 
experiments also demonstrated that microcephaly (i.e; a low level of NSC proliferation 
and more cell death) can be observed as a side effect of ZIKV infection in organoids (98, 
100). Based on this knowledge, another research group employed a unique miniaturised 
spinning bioreactor system to grow forebrain-specific organoids derived from hiPSCs to 
be used as a major platform for high-throughput drug screening (101).  
Techniques for the introduction of microorganisms into organoids  
Organoids are dense 3D structures, which are composed of apical and basal membranes 
as two main compartments. The apical side of the epithelium is toward the lumen 
(inside) of the organoids and the basal membrane appears on the outside. 
Microorganisms tend to target the apical membrane in vivo. Therefore, recapitulating 
the exact interactions between the host and the microbes are crucial. Hence, three 
independent strategies have been developed to reproduce host versus pathogen 
interactions (70). 
I. Infection of dissociated spheroids before forming 3D organoids 
In this technique, organoids are forced to undergo mechanical shear stress or enzymatic 
digestion to become single-cell suspension to expose the apical side. Following infection 
of dissociated cells, the infected cells will be seeded in a 3D matrix to form 3D organoids 
within a few days. This method was employed to study gene expression manipulations 
using a specific lentiviral system (102) and can be used to model different infectious 
disease models (97, 103, 104).  
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II. Microinjection of viruses or bacteria into the lumen side of organoids 
This technique was previously developed to inject ESCs into mice to study genetics. 
With slight modifications, microorganisms can be injected directly into the organoid’s 
lumen (105, 106). As the organoids remain intact and no dissociation occurs, the 
necessary interaction between the host and pathogens can be easily detected and 
monitored. Although this method seems promising, there are some limitations including 
the availability of a microinjector device and precise quantification of delivered 
pathogens can be difficult due to the size variation of organoids in culture (70).  
III. 2D culture derived organoids and interaction with microorganisms 
3D organoids can be dissociated and seeded onto an ECM such as MatrigelTM or 
collagen-coated plates. The cells will expand in 2D and the apical surface will be 
exposed on the surface, therefore, when microorganisms are added to the dish, the 
host-microbe interaction proceeds. With this technique, microbes can be quantified, 
however; it does not resemble the in vivo 3D setting (107).  
Future Directions 
The ability to generate organ-specific organoids using hPSCs or tissue-specific 
progenitor cells alongside the development of cancer organoids has made organoid 
technology a powerful tool to study various biological aspects including organ 
development, tissue morphogenesis, modelling diseases in vitro, and testing the efficacy 
and toxicity of therapeutic compounds (41, 43, 44, 51, 55, 71, 91, 108-112). The 
advancement in microfabrication and microfluidic technology can set the stage for the 
development of new devices to enable high-throughput screening and biosensing, 
which subsequently would expand organoid application as a tool for drug toxicity 
screening of novel compounds (113).  
To achieve the full potential of 3D organoids, it is important to overcome limitations 
associated with current methodologies, particularly phenotypic immaturity of derived 
cells. For instance, suboptimal expression of hepocyte-specific CYP450 enzymes and low 
levels of albumin secretion were reported in liver organoids compared to primary 
hepatocytes, which restricts their downstream industrial and clinical applications (114). 
In addition, MatrigelTM, as an undefined animal product, has been an indispensable 
element of 3D organoid methodologies that would undermine their therapeutic value. 
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Therefore, it is important to develop new methodologies to establish GMP-ready 
protocols for the generation of 3D microtissues by using xeno-free and well-defined 
matrices to facilitate their potential clinical applications.  
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